Abstract:Orexin, also known as hypocretin, is an excitatory neuropeptide discovered in 1998 by 2 independent research teams led by De Lecea and Sakurai. The orexin system comprises orexin A, orexin B, and their corresponding receptors: orexin type 1 receptor and orexin type 2 receptor. This system plays a crucial role in various physiological processes, including the regulation of the sleep/wake cycle, motivation, energy homeostasis, and emotional responses. [ 1–3 ] In the past 2 decades, the number of articles on orexin has surged significantly, [ 4 ] reflecting the growing interest in orexin. Notably, a major milestone was reached when the efficacy of orexin receptor antagonists for treating insomnia was definitively established, leading to their approval for clinical use. [ 5–8 ]

Bibliometric analysis of orexin: A promising neuropeptide